Joseph P. McGuirk, DO

Articles

Innovations in Immunotherapy: CAR T-Cells, Allogeneic Approaches, and Bispecifics

December 12th 2023

Expert perspective on advancements in cancer immunotherapy, including CAR-T cells, allogeneic strategies, and the role of bispecific antibodies.

Challenges in CAR T-Cell Therapy for Lymphoma

December 5th 2023

Delve into the challenges of CAR T-cell therapy access and explore the biology behind treatment responses and relapses in lymphoma patients.

Real-World Use of CAR T-Cell Therapy in Patients with Lymphoma

December 5th 2023

Explore the real-world application of CAR T-cell therapy in lymphoma treatment, from response rates to its role in first-line therapy.

CAR T-Cell Therapy’s Impact on Lymphoma Management

November 28th 2023

Gain insights into CAR T-cell therapy's impact on lymphoma treatment through a historical perspective and mechanism of action.

Advancing Lymphoma Treatments: CAR T-Cell and Bispecific Therapies

November 28th 2023

Discover cutting-edge cellular therapeutics, CAR T-cell therapy, and bispecific strategies for treating lymphoma patients in clinical trials.

Large B-Cell Lymphoma: Treatment Approaches and Evolving Therapies

November 22nd 2023

Expert insight into current treatment strategies and emerging therapies for diffuse large B-cell lymphoma, a challenging malignancy.

Understanding LBCL: Presentation, Diagnosis, and Prognostic Indicators

November 22nd 2023

Explore the diverse ways large B-cell lymphoma can manifest, the diagnostic process, and prognostic indicators for effective management.